The Global Burden of Esophageal Cancer: A Disability-Adjusted Life-Year Approach

Benjamin J. Di Pardo, Nathan Bronson, Brian S. Diggs, Charles Thomas, John Hunter, James Dolan

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Introduction: Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. As a significant cause of morbidity and mortality, its burden on society has yet to be fully characterized. The aim of this study is to examine its global burden through estimation of the disability-adjusted life years (DALYs) attributable to it. Methods: Global incidence and mortality estimates for esophageal cancer were obtained from the International Agency for Research on Cancer GLOBOCAN 2008 database. DALYs were calculated, using methodology established by the World Health Organization. Results: In 2008, 3,955,919 DALYs were attributed to esophageal cancer, at a global rate of 0.58 DALYs per 1000 people annually. Years of life lost (YLL) accounted for 96.8 % of DALYs, while years lived with disability (YLD) accounted for 3.2 %. 83.8 % of the global DALYs occurred in less-developed countries, with most accrued in Eastern Asia, comprising 50.9 % of the total. The highest rate of DALY accrual was in Southern Africa, at 1.62 DALYs per 1000 people annually. Conclusions: A substantial number of years of life were lost or affected by esophageal cancer worldwide in 2008, with the burden resting disproportionately on less-developed countries. Geographically, the greatest burden is in Eastern Asia. The vast majority of DALYs were due to YLL, rather than YLD, indicating the need to focus resources on disease prevention and early detection. Our findings provide an additional basis upon which to formulate global priorities for interventions that affect DALY reduction in esophageal cancer.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalWorld Journal of Surgery
DOIs
StateAccepted/In press - Dec 2 2015

Fingerprint

Quality-Adjusted Life Years
Esophageal Neoplasms
Far East
Developing Countries
International Agencies
Southern Africa
Neoplasms
Mortality
Early Diagnosis
Databases
Morbidity

ASJC Scopus subject areas

  • Surgery

Cite this

The Global Burden of Esophageal Cancer : A Disability-Adjusted Life-Year Approach. / Di Pardo, Benjamin J.; Bronson, Nathan; Diggs, Brian S.; Thomas, Charles; Hunter, John; Dolan, James.

In: World Journal of Surgery, 02.12.2015, p. 1-7.

Research output: Contribution to journalArticle

@article{5cfefa73f8b84737a12abfe525a367f4,
title = "The Global Burden of Esophageal Cancer: A Disability-Adjusted Life-Year Approach",
abstract = "Introduction: Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. As a significant cause of morbidity and mortality, its burden on society has yet to be fully characterized. The aim of this study is to examine its global burden through estimation of the disability-adjusted life years (DALYs) attributable to it. Methods: Global incidence and mortality estimates for esophageal cancer were obtained from the International Agency for Research on Cancer GLOBOCAN 2008 database. DALYs were calculated, using methodology established by the World Health Organization. Results: In 2008, 3,955,919 DALYs were attributed to esophageal cancer, at a global rate of 0.58 DALYs per 1000 people annually. Years of life lost (YLL) accounted for 96.8 {\%} of DALYs, while years lived with disability (YLD) accounted for 3.2 {\%}. 83.8 {\%} of the global DALYs occurred in less-developed countries, with most accrued in Eastern Asia, comprising 50.9 {\%} of the total. The highest rate of DALY accrual was in Southern Africa, at 1.62 DALYs per 1000 people annually. Conclusions: A substantial number of years of life were lost or affected by esophageal cancer worldwide in 2008, with the burden resting disproportionately on less-developed countries. Geographically, the greatest burden is in Eastern Asia. The vast majority of DALYs were due to YLL, rather than YLD, indicating the need to focus resources on disease prevention and early detection. Our findings provide an additional basis upon which to formulate global priorities for interventions that affect DALY reduction in esophageal cancer.",
author = "{Di Pardo}, {Benjamin J.} and Nathan Bronson and Diggs, {Brian S.} and Charles Thomas and John Hunter and James Dolan",
year = "2015",
month = "12",
day = "2",
doi = "10.1007/s00268-015-3356-2",
language = "English (US)",
pages = "1--7",
journal = "World Journal of Surgery",
issn = "0364-2313",
publisher = "Springer New York",

}

TY - JOUR

T1 - The Global Burden of Esophageal Cancer

T2 - A Disability-Adjusted Life-Year Approach

AU - Di Pardo, Benjamin J.

AU - Bronson, Nathan

AU - Diggs, Brian S.

AU - Thomas, Charles

AU - Hunter, John

AU - Dolan, James

PY - 2015/12/2

Y1 - 2015/12/2

N2 - Introduction: Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. As a significant cause of morbidity and mortality, its burden on society has yet to be fully characterized. The aim of this study is to examine its global burden through estimation of the disability-adjusted life years (DALYs) attributable to it. Methods: Global incidence and mortality estimates for esophageal cancer were obtained from the International Agency for Research on Cancer GLOBOCAN 2008 database. DALYs were calculated, using methodology established by the World Health Organization. Results: In 2008, 3,955,919 DALYs were attributed to esophageal cancer, at a global rate of 0.58 DALYs per 1000 people annually. Years of life lost (YLL) accounted for 96.8 % of DALYs, while years lived with disability (YLD) accounted for 3.2 %. 83.8 % of the global DALYs occurred in less-developed countries, with most accrued in Eastern Asia, comprising 50.9 % of the total. The highest rate of DALY accrual was in Southern Africa, at 1.62 DALYs per 1000 people annually. Conclusions: A substantial number of years of life were lost or affected by esophageal cancer worldwide in 2008, with the burden resting disproportionately on less-developed countries. Geographically, the greatest burden is in Eastern Asia. The vast majority of DALYs were due to YLL, rather than YLD, indicating the need to focus resources on disease prevention and early detection. Our findings provide an additional basis upon which to formulate global priorities for interventions that affect DALY reduction in esophageal cancer.

AB - Introduction: Esophageal cancer is the eighth most common cancer worldwide and the sixth leading cause of cancer-related deaths. As a significant cause of morbidity and mortality, its burden on society has yet to be fully characterized. The aim of this study is to examine its global burden through estimation of the disability-adjusted life years (DALYs) attributable to it. Methods: Global incidence and mortality estimates for esophageal cancer were obtained from the International Agency for Research on Cancer GLOBOCAN 2008 database. DALYs were calculated, using methodology established by the World Health Organization. Results: In 2008, 3,955,919 DALYs were attributed to esophageal cancer, at a global rate of 0.58 DALYs per 1000 people annually. Years of life lost (YLL) accounted for 96.8 % of DALYs, while years lived with disability (YLD) accounted for 3.2 %. 83.8 % of the global DALYs occurred in less-developed countries, with most accrued in Eastern Asia, comprising 50.9 % of the total. The highest rate of DALY accrual was in Southern Africa, at 1.62 DALYs per 1000 people annually. Conclusions: A substantial number of years of life were lost or affected by esophageal cancer worldwide in 2008, with the burden resting disproportionately on less-developed countries. Geographically, the greatest burden is in Eastern Asia. The vast majority of DALYs were due to YLL, rather than YLD, indicating the need to focus resources on disease prevention and early detection. Our findings provide an additional basis upon which to formulate global priorities for interventions that affect DALY reduction in esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=84948976412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948976412&partnerID=8YFLogxK

U2 - 10.1007/s00268-015-3356-2

DO - 10.1007/s00268-015-3356-2

M3 - Article

C2 - 26630937

AN - SCOPUS:84955199786

SP - 1

EP - 7

JO - World Journal of Surgery

JF - World Journal of Surgery

SN - 0364-2313

ER -